Literature DB >> 19495827

Glucosamine sulfate--environmental antibacterial activity.

Alexander P Rozin1.   

Abstract

We have recently showed antibacterial activity against E. coli in vitro of a trademark Mega-Gluflex-containing glucosamine sulfate (GS) and chondroitin sulfate (CS). The purpose of this study was to examine the antibacterial activity of GS as a new trademark Arthryl (Manufacturer Rottapharm Ltd, Ireland; Distributor in Israel Rafa Laboratories Ltd) in vitro. We used cabbage and chicken broths and milk (every media of 20 ml) left opened for 1 week with and without Arthryl supplements 1,500 mg, the content of one package of the medication. A similar volume (20 ml) is ingested in taking the medication. Experiments with three repeatable results were taken for consideration. Arthryl inhibited environmental bacterial colonies' growth in every media but fungi growth was not impaired. Milk stayed liquid for the whole week with supplement of the Arthryl compared with sour milk transformation without Arthryl. Sample B showed inhibitory properties of the bacterial colonies on the fungi growth. The sample with Arthryl showed progressive growth of fungi without bacterial growth after 10 days of follow up compared with bacterial growth on media without Arthryl. Glucosamine sulfate as a new trademark Arthryl has environmental antibacterial properties but does not inhibit growth of fungal colonies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19495827     DOI: 10.1007/s10067-009-1209-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

1.  Wound dressing with sustained anti-microbial capability.

Authors:  W K Loke; S K Lau; L L Yong; E Khor; C K Sum
Journal:  J Biomed Mater Res       Date:  2000

Review 2.  Is osteoarthritis an infection-associated disease and a target for chemotherapy?

Authors:  Alexander Rozin
Journal:  Chemotherapy       Date:  2006-12-28       Impact factor: 2.544

3.  Antibacterial activity of glucosamine sulfate and chondroitine sulfate?

Authors:  A P Rozin; M Goldstein; H Sprecher
Journal:  Clin Exp Rheumatol       Date:  2008 May-Jun       Impact factor: 4.473

4.  The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes.

Authors:  Hyun Ah Kim; Mi-La Cho; Hye Young Choi; Chang Sik Yoon; Joo Yeon Jhun; Hey Jwa Oh; Ho-Youn Kim
Journal:  Arthritis Rheum       Date:  2006-07

5.  Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.

Authors:  J Y Reginster; R Deroisy; L C Rovati; R L Lee; E Lejeune; O Bruyere; G Giacovelli; Y Henrotin; J E Dacre; C Gossett
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

6.  The antioxidant activity of glucosamine hydrochloride in vitro.

Authors:  Ronge Xing; Song Liu; Zhanyong Guo; Huahua Yu; Cuiping Li; Xia Ji; Jinhua Feng; Pengcheng Li
Journal:  Bioorg Med Chem       Date:  2005-11-02       Impact factor: 3.641

7.  Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation.

Authors:  Sunil Shaunak; Sharyn Thomas; Elisabetta Gianasi; Antony Godwin; Emma Jones; Ian Teo; Kamiar Mireskandari; Philip Luthert; Ruth Duncan; Steve Patterson; Peng Khaw; Steve Brocchini
Journal:  Nat Biotechnol       Date:  2004-07-18       Impact factor: 54.908

8.  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.

Authors:  Daniel O Clegg; Domenic J Reda; Crystal L Harris; Marguerite A Klein; James R O'Dell; Michele M Hooper; John D Bradley; Clifton O Bingham; Michael H Weisman; Christopher G Jackson; Nancy E Lane; John J Cush; Larry W Moreland; H Ralph Schumacher; Chester V Oddis; Frederick Wolfe; Jerry A Molitor; David E Yocum; Thomas J Schnitzer; Daniel E Furst; Allen D Sawitzke; Helen Shi; Kenneth D Brandt; Roland W Moskowitz; H James Williams
Journal:  N Engl J Med       Date:  2006-02-23       Impact factor: 91.245

9.  Glucosamine and chondroitin sulfate: biological response modifiers of chondrocytes under simulated conditions of joint stress.

Authors:  L Lippiello
Journal:  Osteoarthritis Cartilage       Date:  2003-05       Impact factor: 6.576

10.  Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.

Authors:  Agustín Albillos; Antonio de la Hera; Mónica González; Jose-Luis Moya; Jose-Luis Calleja; Jorge Monserrat; Luis Ruiz-del-Arbol; Melchor Alvarez-Mon
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.